Highlight Therapeutics announces completion of enrollment for Phase 2b study of BO-112 in large, underserved basal cell ...

US FDA acknowledges no filing deficiencies in Biofrontera’s sNDA for Ameluz PDT in superficial basal cell carcinoma: Woburn, Massachusetts Saturday, February 14, 2026, 16:00 Hrs ...

Using razors or home hacks to remove moles can cause severe bleeding, infection, scarring, and even delay skin cancer diagnosis, doctors warn.

A study has examined whether there is a link between skin cancer found on the right side of the face and the side of the road ...

Netflix star Kelli Finglass has been diagnosed with cancer. The TV personality, 61, took to Instagram with a candid video as she opened up about her recent diagnosis. 'Well, good ...

The FDA has accepted a sNDA for Ameluz topical gel, used in combination with the RhodoLED red-light lamp series, for superficial basal cell carcinoma treatment.

The FDA accepted the supplemental new drug application (sNDA) for aminolevulinic acid hydrochloride 10% topical gel (Ameluz) as part of photodynamic therapy (PDT) for superficial basal cell carcinoma ...

Verrica Pharmaceuticals Inc. ("Verrica") (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring ...

Verrica Pharmaceuticals Inc. ('Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling ...

Prescription Drug User Fee Act (PDUFA) target action date set for September 28, 2026If approved, Ameluz would be the first and only PDT photosensitizer indicated for the treatment of superficial Basal ...

The Bump I Ignored: A Personal Warning About Skin Cancer I’ve always been careful with my skin, religiously applying s ...

Prescription Drug User Fee Act (PDUFA) target action date set for September 28, 2026If approved, Ameluz® would be the first and only PDT ...